ET
PRCT icon

Entropy Technologies’s Procept Biorobotics PRCT Stock Holding History

Entropy Technologies’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$623K Buy
27,575
+17,060
+162% +$427K 0.02% 614
2026
Q1 		$263K Buy
10,515
+1,544
+17% +$43.5K 0.01% 733
2025
Q4 		$282K Buy
+8,971
New +$297K 0.02% 722
2025
Q2 		– Sell
-7,100
Closed -$414K – 977
2025
Q1 		$414K Buy
+7,100
New +$485K 0.04% 472

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Entropy Technologies's PRCT Position: Q2 2026 in Review

Entropy Technologies increased its Procept Biorobotics (PRCT) stake by 162% in Q2 2026, buying an estimated $427K and bringing the position to 27,575 shares worth $623K. The position accounts for 0.02% of the portfolio, ranked #614.

Entropy Technologies first reported a position in PRCT in Q1 2025 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Entropy Technologies held 27,575 shares of Procept Biorobotics worth $623K as of Q2 2026.
  • Entropy Technologies bought 17,060 Procept Biorobotics shares in Q2 2026, an estimated $427K.
  • Procept Biorobotics made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #614 holding.
  • Entropy Technologies first reported a position in Procept Biorobotics in Q1 2025 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.